...
首页> 外文期刊>Der Pharma Chemica: journal for medicinal chemistry, pharmaceutical chemistry and computational chemistry >Antimicrobial and antioxidant evaluation of a retro spective siddha formulation Dhasalavana dhravagam used for the treatment of infectious disease
【24h】

Antimicrobial and antioxidant evaluation of a retro spective siddha formulation Dhasalavana dhravagam used for the treatment of infectious disease

机译:回顾性西达制剂Dhasalavana dhravagam用于治疗传染病的抗菌和抗氧化评估

获取原文
           

摘要

The main objective of the present study is to evalu ate the antimicrobial and antioxidant potential of Dhasalavana dhravagam (DLD) a well-known classical drug selecte d from the Siddha classical literature, “Kannusamiy am Ennum Vaidhya Segaram. The antimicrobial property o f the DLD was studied against Gram-negative and Gra m- positive microorganisms using the agar well diffusi on method. The result of antimicrobial screening st udy projects that the drug DLD exhibited bigger zone of inhibiti on of about 08- 26 mm against Staphylococcus aureus followed by this 09- 25 mm of zone against Klebsiella pneumo nia, 09- 24 mm of zone against Bacillus Subtilis an d 07- 22 mm zone against Salmonella typhimurium at the concentr ation of 250mg/ml. Antioxidant potential of DLD wa s evaluated by using DPPH radical scavenging assay. T he result obtained from the study shows that DLD po ssess potential antioxidant activity (91.3%) relatively n ear to the standard drug. From the study it was con cluded that the drug DLD has promising antimicrobial, antioxidant a ctivity and hence this siddha formulation may serve as a prospective drug for treating several infectious di seases in near future.
机译:本研究的主要目的是评估Dhasalavana dhravagam(DLD)的抗菌和抗氧化潜力,Dhasalavana dhravagam是从Siddha古典文献“ Kannusamiy am Ennum Vaidhya Segaram”中选择的著名经典药物。使用琼脂孔扩散法研究了DLD对革兰氏阴性和革兰氏阳性微生物的抗菌特性。抗菌素筛选研究的结果表明,药物DLD对金黄色葡萄球菌的抑制作用范围更大,约为08- 26 mm,随后对肺炎克雷伯菌的抑制作用范围为09-25 mm,对枯草芽孢杆菌的抑制作用范围为09-24 mm浓度为250mg / ml的鼠伤寒沙门氏菌的第7-22毫米区域。采用DPPH自由基清除法评价了DLD的抗氧化能力。从研究中获得的结果表明,相对于标准药物,DLD具有相对潜在的抗氧化活性(91.3%)。从研究中可以得出结论,DLD药物具有良好的抗菌,抗氧化剂功能,因此该siddha制剂可在不久的将来用作治疗多种传染病的前瞻性药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号